Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (234) GO Terms (11) Nucleotides (370) Proteins (50) Interactants (1557) Wiki
XB--484285

Papers associated with tp53



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5

Sort Newest To Oldest Sort Oldest To Newest

referenced by:


p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases., Saha P, Eichbaum Q, Silberman ED, Mayer BJ, Dutta A., Mol Cell Biol. August 1, 1997; 17 (8): 4338-45.


Cloning of the p53 tumor suppressor gene from the Japanese medaka (Oryzias latipes) and evaluation of mutational hotspots in MNNG-exposed fish., Krause MK, Rhodes LD, Van Beneden RJ., Gene. April 11, 1997; 189 (1): 101-6.


Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis., Marechal V, Elenbaas B, Taneyhill L, Piette J, Mechali M, Nicolas JC, Levine AJ, Moreau J., Oncogene. March 27, 1997; 14 (12): 1427-33.


B-Myb, a repressed trans-activating protein., Ansieau S, Kowenz-Leutz E, Dechend R, Leutz A., J Mol Med (Berl). January 1, 1997; 75 (11-12): 815-9.


Biochemical properties of Xenopus laevis p53., Hoever M, Herrmann C, Montenarh M., Int J Oncol. January 1, 1997; 10 (1): 195-203.


Tumour suppressor gene p53 in the horse: identification, cloning, sequencing and a possible role in the pathogenesis of equine sarcoid., Bucher K, Szalai G, Marti E, Griot-Wenk ME, Lazary S, Pauli U., Res Vet Sci. September 1, 1996; 61 (2): 114-9.


Cyclin-binding motifs are essential for the function of p21CIP1., Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A., Mol Cell Biol. September 1, 1996; 16 (9): 4673-82.


The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype., Levine AJ, Wu MC, Chang A, Silver A, Attiyeh EF, Lin J, Epstein CB., Ann N Y Acad Sci. September 30, 1995; 768 111-28.


A direct effect of activated human p53 on nuclear DNA replication., Cox LS, Hupp T, Midgley CA, Lane DP., EMBO J. May 1, 1995; 14 (9): 2099-105.


Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA., Chen J, Jackson PK, Kirschner MW, Dutta A., Nature. March 23, 1995; 374 (6520): 386-8.


Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved., Wang Y, Farmer G, Soussi T, Prives C., Oncogene. February 16, 1995; 10 (4): 779-84.


Fission yeast tmsl protein abrogates normal development in Xenopus laevis embryos., Wagner P, Hoever M, Appel K, Knöchel W, Montenarh M., Rouxs Arch Dev Biol. January 1, 1995; 204 (3): 198-202.


Expression of a homologue of the deleted in colorectal cancer (DCC) gene in the nervous system of developing Xenopus embryos., Pierceall WE, Reale MA, Candia AF, Wright CV, Cho KR, Fearon ER., Dev Biol. December 1, 1994; 166 (2): 654-65.              


Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair., Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ., Curr Biol. December 1, 1994; 4 (12): 1062-8.


Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression., Ridgway PJ, Soussi T, Braithwaite AW., J Virol. November 1, 1994; 68 (11): 7178-87.


Xenopus p53 is biochemically similar to the human tumour suppressor protein p53 and is induced upon DNA damage in somatic cells., Cox LS, Midgley CA, Lane DP., Oncogene. October 1, 1994; 9 (10): 2951-9.


Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases., Strausfeld UP, Howell M, Rempel R, Maller JL, Hunt T, Blow JJ., Curr Biol. October 1, 1994; 4 (10): 876-83.


A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis., Nigro V, Napolitano M, Abbondanza C, Medici N, Puca AA, Schiavulli M, Armetta I, Moncharmont B, Puca GA, Molinari AM., Cancer Lett. April 29, 1994; 79 (1): 73-5.


The canine p53 gene is subject to somatic mutations in thypoid carcinoma., Devilee P, Van Leeuwen IS, Voesten A, Rutteman GR, Vos JH, Cornelisse CJ., Anticancer Res. January 1, 1994; 14 (5A): 2039-46.


Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos., Hoever M, Clement JH, Wedlich D, Montenarh M, Knöchel W., Oncogene. January 1, 1994; 9 (1): 109-20.


Stabilization and expression of high levels of p53 during early development in Xenopus laevis., Tchang F, Gusse M, Soussi T, Méchali M., Dev Biol. September 1, 1993; 159 (1): 163-72.


The Ets family of transcription factors., Wasylyk B, Hahn SL, Giovane A., Eur J Biochem. January 15, 1993; 211 (1-2): 7-18.


Identification of RNA-binding proteins specific to Xenopus Eg maternal mRNAs: association with the portion of Eg2 mRNA that promotes deadenylation in embryos., Legagneux V, Bouvet P, Omilli F, Chevalier S, Osborne HB., Development. December 1, 1992; 116 (4): 1193-202.


Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library., Stephen CW, Lane DP., J Mol Biol. June 5, 1992; 225 (3): 577-83.


p53 mutations in human cancers., Hollstein M, Sidransky D, Vogelstein B, Harris CC., Science. July 5, 1991; 253 (5015): 49-53.


Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines., Bartek J, Iggo R, Gannon J, Lane DP., Oncogene. June 1, 1990; 5 (6): 893-9.


Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form., Gannon JV, Greaves R, Iggo R, Lane DP., EMBO J. May 1, 1990; 9 (5): 1595-602.


Genes and mechanisms involved in early embryonic development in Xenopus laevis., Méchali M, Almouzni G, Andéol Y, Moreau J, Vriz S, Leibovici M, Hourdry J, Géraudie J, Soussi T, Gusse M., Int J Dev Biol. March 1, 1990; 34 (1): 51-9.


Tumor suppressor genes., Levine AJ., Bioessays. February 1, 1990; 12 (2): 60-6.


Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70., Soussi T, Caron de Fromentel C, Stürzbecher HW, Ullrich S, Jenkins J, May P., J Virol. September 1, 1989; 63 (9): 3894-901.


Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen., Jenkins JR, Chumakov P, Addison C, Stürzbecher HW, Wade-Evans A., J Virol. October 1, 1988; 62 (10): 3903-6.


Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53., Soussi T, Caron de Fromentel C, Méchali M, May P, Kress M., Oncogene. March 1, 1987; 1 (1): 71-8.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5